Manuscripts
Showing 1556 manuscripts.
A comparison of tests for restricted orderings in the three-class case
Citation
Todd A. Alonzo, Christos T. Nakas, Constantin Yiannoutsos, Sherri Bucher. A comparison of tests for restricted orderings in the three-class case. Statistics In Medicine. 2009. 28: 1144-58.Year
2009
Journal
Statistics In Medicine
Raltegravir cerebrospinal fluid concentrations in HIV-1 infection
Citation
Aylin Yilmaz, Magnus Gisslen, Serena S. Spudich, Evelyn Lee, Anura L. Jayewardene, Francesca Aweeka, Richard W. Price. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. Public Library of Science One. 2009. 4: e6877 1-5.Year
2009
Journal
Public Library of Science One
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant womenlamivudine in HIV-infected pregnant women.
Citation
Yvonne J. Bryson, Mark Mirochnick, Alice M. Stek, Lynne M. Mofenson, James D. Connor, Edmund Capparelli, Heather D. Watts, Sharon Huang, Michael Hughes, Bethann Cunningham, Lynette Purdue, Yetemegnu Asfaw, Margaret A. Keller, Elizabeth (Betsy) Smith. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant womenlamivudine in HIV-infected pregnant women.. HIV Clinical Trials. 2009. 9: 115-25. PMID: 18474496Year
2009
Journal
HIV Clinical Trials
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients.
Citation
Jennifer R. King, Edward P. Acosta, Ram Yogev, Andrew A. Wiznia, Bobbie L. Graham, Vincent J. Carey, Paula Britto. Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients.. Pediatric Infectious Disease Journal. 2009. 28: 159-161. PMID: 19106779Year
2009
Journal
Pediatric Infectious Disease Journal
Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability.
Citation
Patricia A. Garvie, Joanne Lawford, Patricia M. Flynn, Aditya Gaur, Marvin Eric Belzer, George D. McSherry, Lawrence B. Friedman, ChengCheng Hu. Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability.. Journal of Adolescent Health. 2009. 44: 124-32. PMID: 19167660Year
2009
Journal
Journal of Adolescent Health
Study
P1036A
Allocation of family responsibility for illness management in pediatric HIV.
Citation
Sylvie Naar-King, Grace Montepiedra, Sharon L. Nichols, John J. Farley, Patricia A. Garvie, Betsy Kammerer, Kathleen Malee, Patricia Sirois, Deborah S. Storm. Allocation of family responsibility for illness management in pediatric HIV.. Journal of Pediatrics. 2009. 34: 187-94. PMID: 18586756Year
2009
Journal
Journal of Pediatrics
Study
P1042S
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.
Citation
Anne Butler, Paige L. Williams, Lois C. Howland, Deborah S. Storm, Nancy Hutton, George Seage. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.. Pediatrics. 2009. 123: 935-43. PMID: 19255023Year
2009
Journal
Pediatrics
Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team
Citation
Grace M. Aldrovandi, Jane C. Lindsey, Denise L. Jacobson, Amanda Zadzilka, Elizabeth Sheeran, John ( Jack ) Moye, Peggy R. Borum, William A. Meyer, Dana S. Hardin, Kathleen Mulligan. Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team. AIDS. 2009. 23: 661-72. PMID: 19279441Year
2009
Journal
AIDS
Study
P1045
Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort
Citation
Thomas Valente, Jennifer B. Zogg, Jean Richardson, Andrea Kovacs, Eva A. Operskalski. Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort. Journal of Acquired Immune Deficiency Syndromes. 2009. 52: 514-23. PMID: 19584741Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.
Citation
John W. Sleasman, Brian Robbins, Shane Cross, Jane C. Lindsey, Barbara E. Heckman, H.G. Sprenger, Nancy Tustin, Charles Rose, Gary E. Pakes, Edmund Capparelli, P Poston, E Neal, M Nikanjam. Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.. Clinical Pharmacology & Therapeutics. 2009. 85: 394-401. PMID: 19118380Year
2009
Journal
Clinical Pharmacology & Therapeutics
Study
P1052